Biolocity provides a combination of funding, project management, and consulting resources to early-stage technologies that address an unmet clinical need and have compelling commercial potential. This includes innovations within any clinical discipline with the ability to impact patient health.
Each funding cycle, over $1.5 million in funding and commercialization support is available for distribution. Technology development support is provided through project management, strategy and business planning, marketing, regulatory, and reimbursement consulting. There is no funding limit per project, however budgets are based on commercialization milestones identified as the most critical next step for development during the application process.
